OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,146,000 | -23.2% | 517,133 | -25.6% | 0.79% | -29.6% |
Q2 2022 | $2,794,000 | -18.8% | 695,000 | 0.0% | 1.12% | -2.9% |
Q1 2022 | $3,440,000 | -29.0% | 695,000 | 0.0% | 1.15% | -13.8% |
Q4 2021 | $4,844,000 | -12.9% | 695,000 | +25.0% | 1.34% | -8.4% |
Q3 2021 | $5,560,000 | +53.1% | 556,000 | +117.1% | 1.46% | +73.2% |
Q2 2021 | $3,632,000 | -31.6% | 256,152 | -21.5% | 0.84% | -42.9% |
Q1 2021 | $5,313,000 | -15.3% | 326,174 | +7.6% | 1.48% | -37.0% |
Q4 2020 | $6,276,000 | – | 303,174 | – | 2.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |